BCL6公司
生发中心
下调和上调
生物
转录因子
癌症研究
染色体易位
B细胞
IRF4公司
淋巴瘤
细胞生物学
分子生物学
B细胞受体
作者
Masumichi Saito,Jie Gao,Katia Basso,Yukiko Kitagawa,Paula M. Smith,Govind Bhagat,Alessandra B. Pernis,Laura Pasqualucci,Riccardo Dalla-Favera
出处
期刊:Cancer Cell
[Cell Press]
日期:2007-09-11
卷期号:12 (3): 280-292
被引量:304
标识
DOI:10.1016/j.ccr.2007.08.011
摘要
The BCL6 proto-oncogene encodes a transcriptional repressor necessary for the development of germinal centers (GCs) and directly implicated in lymphomagenesis. Post-GC development of B cells requires BCL6 downregulation, while its constitutive expression caused by chromosomal translocations leads to diffuse large B cell lymphoma (DLBCL). Herein we identify a signaling pathway that downregulates BCL6 expression in normal GC B cells and is blocked in a subset of DLBCL due to alterations in the BCL6 gene. Activation of the CD40 receptor leads to NF-kappaB-mediated induction of the IRF4 transcription factor, which, in turn, represses BCL6 expression by binding to its promoter region. A subset of DLBCL displays chromosomal translocations or mutations that disrupt the IRF4-responsive region in the BCL6 promoter and block its downregulation by CD40 signaling.
科研通智能强力驱动
Strongly Powered by AbleSci AI